SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-012680
Filing Date
2022-02-24
Accepted
2022-02-24 16:16:21
Documents
2
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1599
2 POA DOCUMENT poa.txt EX-24 4404
  Complete submission text file 0001209191-22-012680.txt   7570
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203
Business Address
Annoni Joe (Reporting) CIK: 0001910431 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38112 | Film No.: 22671177